K Yanagihara, K Tomono, T Sawai, Y Hirakata, J Kadota, H Koga, T Tashiro and S Kohno
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

In a newly established murine model of chronic Pseudomonas aeruginosa respiratory infection mimicking diffuse panbronchiolitis (DPB), we investigated the effect of oral administration of clarithromycin on lymphocyte accumulation in the lung. Infection was produced by placement of a plastic tube precoated with P. aeruginosa in the bronchus. The number of bacteria on the tube was 6.25 +/- 0.22 log10 colony-forming units (cfu)/ml. Viable bacteria were constantly isolated at 10(5) to 10(6) cfu/specimen from the lungs for more than 1 yr. The histopathologic features resembled those of DPB consisting of massive accumulation of lymphocytes in the lung. The total number of pulmonary lymphocytes started to increase on Day 7, reaching a peak level within 12 d of intratracheal challenge. The number remained steady at that level for up to 120 d. There was also a steady fall in the CD4+/CD8+ ratio in the lungs, commencing on Day 7 and persisting to Day 120. A 10- d course of oral clarithromycin (10 mg/kg/d) from Day 7 resulted in a reduction of lymphocyte numbers to baseline level, although the dose did not influence the number of bacteria in the lungs. Treatment also increased the CD4+/CD8+ ratio to the baseline level from Day 7 to 17. Our results were similar to those detected in bronchoalveolar lavage fluid of patients with DPB and suggest that the therapeutic benefits of clarithromycin are due to its anti-inflammatory properties rather than antimicrobial effect.

This article has been cited by other articles:

				Y. Morinaga, K. Yanagihara, S. Nakamura, K. Yamamoto, K. Izumikawa, M. Seki, H. Kakeya, Y. Yamamoto, Y. Yamada, S. Kohno, et al. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model J. Antimicrob. Chemother., October 3, 2008; (2008) dkn411v1. [Abstract] [Full Text] [PDF]

				B. S. Murphy, V. Sundareshan, T. J. Cory, D. Hayes Jr, M. I. Anstead, and D. J. Feola Azithromycin alters macrophage phenotype J. Antimicrob. Chemother., March 1, 2008; 61(3): 554 - 560. [Abstract] [Full Text] [PDF]

				Y. Imamura, K. Yanagihara, Y. Fukuda, Y. Kaneko, M. Seki, K. Izumikawa, Y. Miyazaki, Y. Hirakata, T. Sawa, J. P. Wiener-Kronish, et al. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Eur. Respir. J., May 1, 2007; 29(5): 965 - 968. [Abstract] [Full Text] [PDF]

				Y. Imamura, K. Yanagihara, K. Tomono, H. Ohno, Y. Higashiyama, Y. Miyazaki, Y. Hirakata, Y. Mizuta, J.-i. Kadota, K. Tsukamoto, et al. Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection J. Med. Microbiol., June 1, 2005; 54(6): 515 - 518. [Abstract] [Full Text] [PDF]

				P. M. Barker, D. J. Gillie, M. S. Schechter, and B. K. Rubin Effect of Macrolides on In Vivo Ion Transport across Cystic Fibrosis Nasal Epithelium Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 868 - 871. [Abstract] [Full Text] [PDF]

				S C Bell, S L Senini, and J G McCormack Macrolides in cystic fibrosis Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98. [Abstract] [PDF]

				L. M. Mashburn, A. M. Jett, D. R. Akins, and M. Whiteley Staphylococcus aureus Serves as an Iron Source for Pseudomonas aeruginosa during In Vivo Coculture J. Bacteriol., January 15, 2005; 187(2): 554 - 566. [Abstract] [Full Text] [PDF]

				W. C. Tsai, M. L. Rodriguez, K. S. Young, J. C. Deng, V. J. Thannickal, K. Tateda, M. B. Hershenson, and T. J. Standiford Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1331 - 1339. [Abstract] [Full Text] [PDF]

				T. Nagata, H. Mukae, J. Kadota, T. Hayashi, T. Fujii, M. Kuroki, R. Shirai, K. Yanagihara, K. Tomono, T. Koji, et al. Effect of Erythromycin on Chronic Respiratory Infection Caused by Pseudomonas aeruginosa with Biofilm Formation in an Experimental Murine Model Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2251 - 2259. [Abstract] [Full Text] [PDF]

				Y. Kaneko, K. Yanagihara, M. Seki, M. Kuroki, Y. Miyazaki, Y. Hirakata, H. Mukae, K. Tomono, J.-i. Kadota, and S. Kohno Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L847 - L853. [Abstract] [Full Text] [PDF]

				K. Yanagihara, K. Tomono, Y. Kaneko, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, H. Mukae, J.-i. Kadota, I. Murata, and S. Kohno Role of elastase in a mouse model of chronic respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis J. Med. Microbiol., June 1, 2003; 52(6): 531 - 535. [Abstract] [Full Text] [PDF]

				S. Aoki, Y. Hirakata, Y. Miyazaki, K. Izumikawa, K. Yanagihara, K. Tomono, Y. Yamada, T. Tashiro, S. Kohno, and S. Kamihira Detection of Legionella DNA by PCR of whole-blood samples in a mouse model J. Med. Microbiol., April 1, 2003; 52(4): 325 - 329. [Abstract] [Full Text] [PDF]

				K. Yanagihara, K. Tomono, Y. Imamura, Y. Kaneko, M. Kuroki, T. Sawai, Y. Miyazaki, Y. Hirakata, H. Mukae, J.-I. Kadota, et al. Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model J. Antimicrob. Chemother., May 1, 2002; 49(5): 867 - 870. [Abstract] [Full Text] [PDF]

				K. Yanagihara, K. Tomono, T. Sawai, M. Kuroki, Y. Kaneko, H. Ohno, Y. Higashiyama, Y. Miyazaki, Y. Hirakata, S. Maesaki, et al. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation J. Antimicrob. Chemother., July 1, 2000; 46(1): 69 - 72. [Abstract] [Full Text] [PDF]

				S. Abe, H. Nakamura, S. Inoue, H. Takeda, H. Saito, S. Kato, N. Mukaida, K. Matsushima, and H. Tomoike Interleukin-8 Gene Repression by Clarithromycin Is Mediated by the Activator Protein-1 Binding Site in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 51 - 60. [Abstract] [Full Text]

				A. Rutman, R. Dowling, P. Wills, C. Feldman, P. J. Cole, and R. Wilson Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa Antimicrob. Agents Chemother., April 1, 1998; 42(4): 772 - 778. [Abstract] [Full Text]